Home Your Impact Supporting clinical trials and research

We proudly fund and sponsor clinical trials across Australia to benefit people with cancer

Icon Cancer Foundation is dedicated to improving access to advanced treatments for cancer through promoting and funding investigator initiated clinical trials.

Currently, we support more than ten clinical trials for cancer patients across Australia. These clinical trials:

conduct research on the safety and effectiveness of new medications and treatment
confirm the use of new treatments compared to the current standard of care
study the effects on early detection, cancer prevention and quality of life

Many other trials are also under development and will be available for patients in the future. Our goal is to continue to contribute to the development of new cancer treatments and techniques that will make a lasting difference.

Clinical trials supported by Icon Cancer FoundationClinical trials supported by Icon Cancer Foundation

LIBERATE

Clinical registry of focal low dose rate brachytherapy in men with biopsy confirmed low-intermediate risk prostate cancer (LIBERATE)

Locations
Epworth Richmond, Epworth Freemasons, Geelong

Diagnosis
Prostate cancer

View Trial

TREMOR

Safety and effectiveness of frameless linac-based stereotactic radiosurgery on tremor in patients with essential tremor or Parkinson’s disease (TREMOR study)

Locations
Epworth Richmond

Diagnosis
Neurological conditions

View Trial

CONSOLE

Conventional or Stereotactic Radiotherapy for the palliation of non-spine bone metastases: A randomised phase III trial. (CONSOLE)

Locations
Wahroonga

Diagnosis
Advanced solid tumours

View Trial